Navigating CLL Management: Insights from a Clinical Pharmacist at Mount Sinai Hospital
January 17th 2024Kyle Farina, PharmD, BCPS, BCOP, addresses the multifaceted role of pharmacists in CLL management, including their role in patient care, treatment decision support, and addressing safety considerations.
Watch
Assessing Philadelphia-Like B-Cell ALL in a Largely Hispanic Population
Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.
Read More
FDA Approves IgG-Hyaluronidase Recombinant for the Treatment of Adult Patients With CIDP
January 16th 2024Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.
Read More